STOCK TITAN
  1. Home
  2. Sec-filings
  3. ACTU
  4. [Form 3] ACTUATE THERAPEUTICS, INC. Initial Statement of Beneficial Ownership

Director Huber granted 30,000 Actuate (ACTU) stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

ACTUATE THERAPEUTICS, INC. director Dr. Martin H. Huber Jr. reported an initial holding of non-qualified stock options on Common Stock. He was granted 30,000 stock options upon joining the Board of Directors, with an exercise price of $3.00 per share and expiration on May 1, 2036.

The grant vests in three equal installments on the first, second, and third anniversaries of the grant date, contingent on his continued service. Following this grant, he holds derivative rights over 30,000 underlying shares through these options, representing equity-based compensation rather than an open-market trade.

Positive

  • None.

Negative

  • None.
Insider Huber Martin H. Jr.
Role null
Type Security Shares Price Value
holding Non-Qualified Stock Options -- -- --
Holdings After Transaction: Non-Qualified Stock Options — 30,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Stock options granted 30,000 options Non-qualified stock options on Common Stock
Exercise price $3.00 per share Exercise price for non-qualified stock options
Underlying shares 30,000 shares Common Stock underlying the options
Option expiration May 1, 2036 Expiration date of non-qualified stock options
Vesting schedule 3 equal annual installments First, second, and third anniversaries of grant date
Non-Qualified Stock Options financial
"security_title: "Non-Qualified Stock Options""
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
exercise price financial
"conversion_or_exercise_price: "3.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"option shall vest in three equal installments on the first, second, and third anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Board of Directors financial
"upon his appointment to the Board of Directors of Actuate Therapeutics, Inc."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Huber Martin H. Jr.
(Last)(First)(Middle)
C/O ACTUATE THERAPEUTICS, INC.
1751 RIVER RUN, SUITE 400
(Street)
FORT WORTH TEXAS 76107
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026		3. Issuer Name and Ticker or Trading Symbol
ACTUATE THERAPEUTICS, INC. [ ACTU ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Options (1)05/01/2036Common Stock30,000$3D
Explanation of Responses:
1. 30,000 stock options were granted to Dr. Huber upon his appointment to the Board of Directors of Actuate Therapeutics, Inc., which option shall vest in three equal installments on the first, second, and third anniversary of the grant date, subject to the reporting person's continued service through each such vesting date.
/s/ Paul Lytle, Attorney-in-Fact05/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider position is reported for ACTU director Martin H. Huber Jr. on this Form 3?

Dr. Martin H. Huber Jr., a director of ACTUATE THERAPEUTICS, INC. (ACTU), reports holding non-qualified stock options. These options give him rights over 30,000 shares of Common Stock as equity-based compensation tied to his Board service.

How many stock options did ACTU director Huber receive and at what exercise price?

Dr. Huber received 30,000 non-qualified stock options with an exercise price of $3.00 per share. These options relate to ACTUATE THERAPEUTICS, INC. Common Stock and form part of his compensation as a member of the company’s Board of Directors.

What is the vesting schedule for the 30,000 ACTU stock options granted to Huber?

The 30,000 stock options granted to Dr. Huber vest in three equal installments. Vesting occurs on the first, second, and third anniversaries of the grant date, and each installment requires his continued service on the ACTUATE THERAPEUTICS, INC. Board through the applicable vesting date.

When do Dr. Huber’s ACTU stock options expire and what stock do they cover?

Dr. Huber’s non-qualified stock options expire on May 1, 2036, if not exercised earlier. They are exercisable for ACTUATE THERAPEUTICS, INC. Common Stock and currently relate to 30,000 underlying shares as reported in the derivative holdings summary.

Does this ACTU Form 3 show any open-market buying or selling by Dr. Huber?

The Form 3 reflects an initial holding of non-qualified stock options granted as compensation, not an open-market trade. It shows derivative rights over 30,000 shares with a $3.00 exercise price, without any reported open-market purchases or sales of ACTU Common Stock.